Only members of the media with an approved press badge will have access to press conferences and the press room during hours of operation.

Public relations and industry executives and representatives will not have access to the press room and are prohibited from soliciting media in or around the press room. They may, however, call upon the press room staff to help them facilitate media requests.

Company or product literature, statements, or news releases may not be distributed in the adjacent hallways and areas around the press conference and press room. Only preapproved media materials may be made available in the press area. Press releases must mention VIVA Physicians and/or VIVA 2019 in order to be placed in the press area (see News Release Policy.)


VIVA will host press conferences on Monday, November 4 and Tuesday, November 5 featuring abbreviated presentations of the Late-Breaking Clinical Trials that will be presented during the general session the following day. Presenters will have 5 minutes to present result highlights, followed by 5 minutes of questions from the press.


Late-Breaking Clinical Trials

VIVA embargoes information presented as Late-Breaking Clinical Trials from publication until after the beginning of the Late-Breaking Clinical Trial session in the Global Theater as listed in the VIVA 2019 Program or on the official VIVA 2019 website. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented. All embargo times are listed in Pacific Daylight Time (PDT).


VIVA Physicians, Inc. (VPI) accepts comments and discussions via our social media outlets related to vascular education. VPI does not solicit nor endorse any comment which may be posted, and comments, likes, or follows do not express the opinion or views of VPI. VPI will remove any information, discussion, comment, and material that we deem to be inappropriate and/or which violates our policy to protect patient identities. All commentary with a promotional purpose for a service, device, or technology will be removed immediately. VPI assumes no liability for information posted or presented by others and only endorses comments and postings provided directly by VPI.

VIVA encourages and promotes the exchange and accessibility of educational content from the conference. All videos and slides are available immediately at no charge to attendees through Virtual VIVA. Non-flash photography, audio, and video recordings with handheld devices are permitted for social, personal, or educational purposes, if not disruptive. However, any posting or live streaming of entire sessions or live cases and use of any VIVA course content for commercial purposes is strictly prohibited.


Industry may display news releases in the press area provided they adhere to the following policy:

  • Only companies exhibiting or presenting research at VIVA 2019 may display materials in the press area. All press materials must relate directly to the meeting. VIVA reserves the right to prohibit and/or discard materials deemed scientifically misleading, ethically questionable, or irrelevant to the meeting.
  • All news releases must abide by VIVA’s embargo policy and should not be displayed or released in the press area prior to the embargo date and time.
  • Releases must reference VIVA Physicians or VIVA 2019 in the body of the release, preferably in the first paragraph. Suggested language is provided below.
  • A copy of the press release, or draft press release, must be submitted in advance for review and approval. For advance approval on press releases, please send the press release to News releases will be held in the strictest confidence.

VIVA Press Office Contact:


VIVA Physicians strives to be the premier educator in the field of vascular medicine and intervention. Our team of specialists is driven by the passion to advance the field of vascular medicine with a spirit of collegiality by synergizing their collective talents to promote awareness and innovative therapeutic options for vascular disease worldwide. To learn more about VIVA Physicians, visit

These policies were last updated April 11, 2019, and are subject to change. Please check with the VIVA Press Office for further updates.